MTI : Financial Results Presentation for Q3 FY2023
August 18, 2023 at 04:59 am EDT
Share
Financial Results Briefing
for Q3 FY2023
August 9, 2023
This report contains forward-looking statements on business performance based on the judgments, assumptions, and beliefs of management using the information available at the time. Actual results may differ materially due to changes in domestic or overseas economic conditions or changes in internal or external business environments or aspects of uncertainty contained in the forecasts, latent risks or various other factors. In addition, risk and uncertainty factors include unpredictable elements that could arise from future events.
Contents
P.01 Financial Results
P.16 Measures to be adopted
Overview for Q3 FY2023
02
Financial highlight
17 Basic policies and priority issues
03
Consolidated P/L
for FY2023
04
Consolidated SG&A
18 Cloud drug record service
05
Performance by segment
20 Maternal and child health handbook app
+ Childcare DX services
25
School DX business
28
Image of medium-term profit
P.30 Appendix
31
Earning forecast of FY2023
39
The list of main healthcare services
32
Consolidated B/S
40
Overview of healthcare services
33
Trends in consolidated P/L
41
Cloud drug record service
34
Trends in consolidated SG&A
43
Maternal and child health handbook
35
Performance by segment
47
School DX business
Copyrights (c) 2023 MTI Ltd. All Right Reserved
Financial Results Overview
for Q3 FY2023
Copyrights (c) 2023 MTI Ltd. All Right Reserved
1
Financial highlight
Operating income decreased, profit for the period increased.
・Net sales: ¥20,113 million (+¥758 million, YoY)
・Operating income: ¥(17) million (-¥440million, YoY)
Loss-makingprojects in DX support business for major companies.
Profit attributable to owners of parent: ¥495 million (+¥583 million, YoY)
873 million yen recorded as consumption tax refund (extraordinary income).
2 Healthcare business: Trend of contracting losses continued.
School DX business: Trend of contracting losses continued.
Other business: Loss-making projects in the DX support business for companies continued being handled with the aim of winding them down.
Copyrights (c) 2023 MTI Ltd. All Right Reserved
2
Consolidated P/L
Net sales : increased
Operating income : decreased, ordinary income and profit: increased
（Unit：Mil yen）
FY2022
Q3
Net sales
19,354
Cost of sales
5,756
（ratio)
29.7%
Gross profit
13,597
（ratio）
70.3%
SG&A
13,175
（ratio）
68.1%
Operating income
422
（ratio）
2.2%
Ordinary income
87
（ratio）
0.5%
Profit attributable to
(88)
owners of parent
（ratio）
(0.5)%
YoY
Amount Percentage
+758 +3.9%
+739 +12.8%
+19 +0.1%
+460
+3.5%
-% +63 +72.4%
+583
-%
Q1: Posting of spot sales of the video- streaming service
Posting of spot cost of sales of the video- streaming service
Increase in advertising expenses (AdGuard)
Q3: Recording of extraordinary income for consumption tax refund, etc., of 873 million yen
Copyrights (c) 2023 MTI Ltd. All Right Reserved
3
Attachments
Original Link
Original Document
Permalink
Disclaimer
MTI Ltd. published this content on 18 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 August 2023 08:58:06 UTC.
MTI Ltd. is a Japan-based company mainly engaged in the distribution of contents. The Company is mainly engaged in the distribution of mobile phone contents, including music, life information and entertainment contents. Through its consolidated subsidiaries and associated companies, the Company is also engaged in the operation of advertising agents and the development of software, and the provision of billing and payment platform. The Company is also engaged in the planning, development and operation of Internet business, as well as the research and development of medical information systems.
MTI LTD. 
